Thursday, 17 May 2012 | Source: The Associated Press
Alkermes PLC said Thursday it took a larger loss in its fiscal fourth quarter after it acquired a drug technology business and took a one-time charge related to research and development.
Monday, 30 Jan 2012 | Posted By:
| Source: CNBC.com
Stocks cut most of their earlier losses, but still finished in negative territory Monday as ongoing worries over the euro zone debt crisis kept investors from fully jumping in.
Posts |
COMPANY : Alkermes Inc
10 May 2012
The "Mad Money" host learns more about this biotechnology company, which he thinks is a great speculative stock.... Read More
9 Jan 2012
Alkermes expects FDA approval for its new diabetes drug this month, but that might not be enough to make the stock worth buying, trader Guy Adami said... Read More
Data is a real-time snapshot *Data is delayed at least 15 minutesGlobal Business and Financial News, Stock Quotes, and Market Data and Analysis
© 2012 CNBC LLC. All Rights Reserved.
